Effect of indacaterol/glycopyrronium on ventilation/perfusion match and ventilation dynamics in hyperinflated COPD patients: The CLAIM study
A. Voskrebenzev (Hannover, Germany), T. Kaireit (Hannover, Germany), F. Klimeš (Hannover, Germany), G. Pöhler (Hannover, Germany), L. Behrendt (Hannover, Germany), K. Berschneider (Nuremberg, Germany), F. Wacker (Hannover, Germany), T. Welte (Hannover, Germany), J. Hohlfeld (Hannover, Germany), J. Vogel-Claussen (Hannover, Germany)
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Disease area: Airway diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Voskrebenzev (Hannover, Germany), T. Kaireit (Hannover, Germany), F. Klimeš (Hannover, Germany), G. Pöhler (Hannover, Germany), L. Behrendt (Hannover, Germany), K. Berschneider (Nuremberg, Germany), F. Wacker (Hannover, Germany), T. Welte (Hannover, Germany), J. Hohlfeld (Hannover, Germany), J. Vogel-Claussen (Hannover, Germany). Effect of indacaterol/glycopyrronium on ventilation/perfusion match and ventilation dynamics in hyperinflated COPD patients: The CLAIM study. 3381
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: